Rusty peritoneal dialysis fluid after intravenous administration of iron dextran

被引:11
|
作者
Carter, TB
Garris, AG
Ullian, ME
机构
[1] MED UNIV S CAROLINA, DIV NEPHROL, CHARLESTON, SC 29425 USA
[2] RALPH H JOHNSON VET ADM MED CTR, CHARLESTON, SC USA
关键词
iron dextran; rifampicin; peritoneal dialysis; peritonitis;
D O I
10.1016/S0272-6386(96)90044-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rusty-colored peritoneal dialysate fluid was observed after intravenous administration of iron dextran to a patient with peritonitis being treated with vancomycin and rifampicin. The discoloration gradually cleared over a 24-hour period. Analysis of the fluid demonstrated that the discoloration could not be explained by the presence of erythrocytes or free hemoglobin, Iron (52 mu g/dL) was detected in the fluid and decreased to undetectable levels as the discoloration cleared, Addition of iron dextran to an unused bag of peritoneal dialysis fluid to achieve an iron concentration of 52 mu g/dL resulted in no discoloration, Addition of rifampicin at a clinically relevant serum concentration (10 mu g/mL) to a different unused bag caused a light orange discoloration, Addition of iron dextran and rifampicin simultaneously in the concentrations mentioned to an unused bag caused a rusty discoloration almost as dark as that observed in our patient, We postulate, therefore, that a combination of iron and rifampicin caused the marked discoloration of our patient's peritoneal effluent.
引用
收藏
页码:147 / 150
页数:4
相关论文
共 50 条
  • [1] Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis
    Ficheux, Maxence
    Cuny, Pascale
    Lecouf, Angelique
    Ryckelynck, Jean-Philippe
    de Ligny, Bruno Hurault
    Lobbedez, Thierry
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2011, 7 (07): : 558 - 561
  • [2] Incidence of peritonitis in chronic peritoneal dialysis patients infused with intravenous iron dextran
    Allen, JR
    Troidle, LK
    Juergensen, PH
    Kliger, AS
    Finkelstein, FO
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2000, 20 (06): : 674 - 678
  • [3] USE OF DEXTRAN AS A DIALYSING FLUID IN PERITONEAL DIALYSIS
    GJESSING, J
    [J]. ACTA MEDICA SCANDINAVICA, 1969, 185 (03): : 237 - +
  • [4] Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients
    Prakash, S
    Walele, A
    Dimkovic, N
    Bargman, J
    Vas, S
    Oreopoulos, D
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (03): : 290 - 295
  • [5] Re:: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients
    Hörl, W
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (05): : 527 - 528
  • [6] Stability of iron dextran (DexFerrum) in peritoneal dialysis bags
    Manley, HJ
    Grabe, DW
    Bailie, GR
    Norcross, ML
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (05): : 538 - 540
  • [7] Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin
    Ahsan, N
    Groff, JA
    Waybill, MA
    [J]. ADVANCES IN PERITONEAL DIALYSIS/1996, VOL 12, 1996, 12 : 161 - 166
  • [8] Chronic administration of iron dextran into the peritoneal cavity of rats
    Frajewicki, V
    Kohan, R
    Shostak, A
    Gotloib, L
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 (06): : 616 - 616
  • [9] Chronic administration of iron dextran into the peritoneal cavity of rats
    Park, SE
    Twardowski, ZJ
    Moore, HL
    Khanna, R
    Nolph, KD
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 (02): : 179 - 185
  • [10] Intravenous and subcutaneous administration of trastuzumab in a patient on peritoneal dialysis
    Kokkali, Stefania
    Ternant, David
    Kemmel, Veronique
    Leveque, Dominique
    Wendling, Frederique
    Barthelemy, Philippe
    Kurtz, Jean-Emmanuel
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3372 - 3374